Founded
31 Dec 2001
Address
Visiogen Inc
2 Goodyear Suite B
Irvine, CA 92618
United States
Phone
Website
Business classification
VCID: 127173
Profile
Corporate information
Official name
Visiogen Incorporated
Registration country
Official identities
US CIK 0001144346
Official name
Visiogen Incorporated
Registration country
Official identities
US CIK 0001144346
Investment activity status
Active investor
Company type
A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss.Funding
Funding rounds
Acquisition USD 400,000,000
USD 400,000,000 (3 Oct 2009) at USD 400,000,000 valuation.
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Abbott Laboratories | United States | USD 400,000,000 (USD 400,000,000). Initial investment. Round participant. |
Series D USD 40,000,000
USD 40,000,000 (1 May 2009)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CMEA Capital | United States | Initial investment. Round participant. | |
|
Foundation Medical Partners | United States | Initial investment. Round participant. | |
|
New Leaf Venture Partners | United States | Initial investment. Round participant. | |
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | Initial investment. Round participant. |
|
Prospect Venture Partners | Venture capital firm | United States | Initial investment. Round participant. |
|
Technology Partners. | Venture capital firm | United States | Initial investment. Round participant. |
|
Three Arch Partners LP | Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. | United States | Initial investment. Round participant. |
N/A USD 24,000,000
USD 24,000,000 (1 Feb 2007)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
CMEA Capital | United States | Initial investment. Round participant. |
Venture USD 16,500,000
USD 16,500,000 (1 Dec 2003)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Prospect Venture Partners | Venture capital firm | United States | Initial investment. Round participant. |
|
The Sprout Group | Venture capital affiliate of Credit Suisse | United States | Initial investment. Round participant. |
|
|
Three Arch Partners LP | Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. | United States | Initial investment. Round participant. |
Series B USD 5,000,000
USD 5,000,000 (1 Jul 2002)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
The Sprout Group | Venture capital affiliate of Credit Suisse | United States | Initial investment. Round participant. |
|
|
Three Arch Partners LP | Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. | United States | Initial investment. Round participant. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Pinnacle Ventures LLC | Venture capital firm that focuses on providing debt and equity financing to growing companies. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Abbott Laboratories |
+1 (847) 937-6100 |
Acquisition |
|
|
CMEA Capital |
+1 (415) 352-1520 |
N/A Series D |
|
|
Foundation Medical Partners |
+1 (203) 851-3900 |
Series D |
|
|
New Leaf Venture Partners |
+1 (646) 871-6400 |
Series D |
|
Novartis Services Inc |
+1 (617) 871-3536 |
N/A |
|
|
Novartis Venture Funds The corporate venturing arm of Novartis. |
+41 (61) 324-6210 |
Series D |
|
|
Pinnacle Ventures LLC Venture capital firm that focuses on providing debt and equity financing to growing companies. |
+1 (650) 926-7800 |
N/A |
|
|
Prospect Venture Partners Venture capital firm |
+1 (650) 327-8800 |
Series D Venture |
|
|
Technology Partners. Venture capital firm |
+1 (650) 289-9000 |
Series D |
|
|
The Sprout Group Venture capital affiliate of Credit Suisse |
Series B Venture |
|
|
|
Three Arch Partners LP Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. |
+1 (650) 529-8000 |
Series B Series D Venture |